Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 315,574 | 290,562 | 298,370 | 375,891 | 334,921 |
| Cost of Goods | 32,060 | 35,552 | 41,515 | 41,049 | 34,450 |
| Gross Profit | 283,514 | 255,010 | 256,855 | 334,842 | 300,471 |
| Operating Expenses | 217,353 | 259,056 | 241,435 | 225,667 | 206,833 |
| Operating Income | 66,221 | -3,494 | 15,935 | 109,224 | 94,088 |
| Other Income | 14,612 | 12,527 | 7,822 | 8,057 | 5,894 |
| Pre-tax Income | 80,833 | 9,033 | 23,757 | 117,281 | 99,982 |
| Income Tax | 13,252 | -875 | 7,352 | 21,398 | 20,534 |
| Net Income Continuous | 67,581 | 9,908 | 16,405 | 95,883 | 79,448 |
| Minority Interests | 600 | 722 | 6 | 187 | 73 |
| Net Income | $66,981 | $9,186 | $16,399 | $95,696 | $79,375 |
| EPS Basic Total Ops | 0.70 | 0.10 | 0.17 | 1.00 | 0.83 |
| EPS Basic Continuous Ops | 0.71 | 0.10 | 0.17 | 1.00 | 0.83 |
| EPS Diluted Total Ops | 0.69 | 0.08 | 0.17 | 0.98 | 0.82 |
| EPS Diluted Continuous Ops | 0.69 | 0.09 | 0.17 | 0.99 | 0.82 |
| EBITDA(a) | $86,286 | $20,082 | $40,023 | $133,771 | $116,531 |